Thanks @8horse Nice comparison. They paid cash too.
FYI ... here is the link to Biogen's Investor Briefing on 28 July 2023 about their proposed takeover of Reata back then.
Worth a listen as it also talks about its global sales ambition. Already generating U$1bn free cash flow per year before acquisition.
Also, Biogen is presenting at the Morgan Stanley 21st Annual Global Healthcare Conference on 11 Sep 2023. Wait for recording.
Interesting proposition you pose: Are Acadia and NEU potential takeover targets by Biogen?
GLTA
Thanks @8horse Nice comparison. They paid cash too.FYI ... here...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.000(0.00%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.689M | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1132 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |